Clincosm LogoSign in Get a demo

acute myelogenous leukemia

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • AML
    • DC AML Vaccine
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 25, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

    Recruiting
    • Acute Myelogenous Leukemia
    • Boston, Massachusetts
    • +1 more
    Nov 15, 2021

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • Birmingham, Alabama
    • +16 more
    Apr 14, 2021

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Acute Myeloid Leukemia
    • MCLA-117 bispecific antibody
    • Augusta, Georgia
    • +9 more
    May 6, 2021

    Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

    Completed
    • Related Donors Donating PBSC to a Family Member
    • +7 more
    • Tampa, Florida
    • +11 more
    Sep 3, 2020

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • Infusion of one MPC expanded cord unit and one unexpanded cord unit
    • Infusion of two unexpanded cord blood units.
    • Miami, Florida
    • +8 more
    Jun 25, 2020

    Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)

    Completed
    • Acute Myelogenous Leukemia
    • Brentuximab Vedotin
    • +3 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 12, 2020

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (drug, radiation, biological)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Dec 29, 2018

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,

    Completed
    • Acute Myeloid Leukemia
    • Acute Myelogenous Leukemia
    • Standard dose cytarabine for induction
    • +3 more
    • Birmingham, Alabama
    • +12 more
    May 8, 2018

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia Trial in United States (HMA, SGN-CD33A)

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • Birmingham, Alabama
    • +13 more
    Jan 3, 2018

    Acute Myeloid Leukemia (AML), Acute Myelocytic Leukemia, Acute Myelogenous Leukemia Trial in Boston (Lenalidomide,

    Terminated
    • Acute Myeloid Leukemia (AML)
    • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 15, 2017

    Acute Myelogenous Leukemia Trial in Boston (Cytarabine, Idarubicin, Alisertib)

    Completed
    • Acute Myelogenous Leukemia
    • Boston, Massachusetts
    • +2 more
    Feb 15, 2017

    Acute Myelogenous Leukemia Trial in Boston (Lenalidomide, Mitoxantrone, Etoposide)

    Completed
    • Acute Myelogenous Leukemia
    • Boston, Massachusetts
    • +2 more
    Mar 15, 2016

    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • BMS-936564 (Anti-CXCR4)
    • Birmingham, Alabama
    • +10 more
    Mar 5, 2015

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • Acute Myeloid Leukemia
    • Phoenix, Arizona
    • +19 more
    Mar 17, 2014

    Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • clofarabine (IV formulation)
    • +2 more
    • Scottsdale, Arizona
    • +56 more
    Mar 17, 2014

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Birmingham, Alabama
    • +12 more
    Mar 17, 2014

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in United States (MLN4924, Azacitidine)

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • Stanford, California
    • +5 more
    Dec 3, 2013